Investigation about the influence that prescription of the different latter period second generation antihistamine gives the satisfaction of the cedar pollinosis patient.

Investigation about the influence that prescription of the different latter period second generation antihistamine gives the satisfaction of the cedar pollinosis patient. - An efficacy competitive study of the antihistamine.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004999

Enrollment

150

Registered

2011-02-02

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cedar or hinoki pollinosis

Interventions

olopatadine hydrochloride therapy fexofenadine hydrochloride therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cedar pollinosis confirmed at the site, the following criteria must be met; (1)7 years old and more than it. (2)Sex no object. (3)No objectaccording to a thing of hospitalization / an outpatient. (4)The patient whom disease severity is more than seriously ill in "Practical Guideline for the Management of Allergic Rhinitis in Japan".

Exclusion criteria

Exclusion criteria: (1)The patient who has comlications of a nose disease of the degree to disturb an effect judgment. (2)The patient that the symptom change is remarkable. (3)The patient who must use the drug which has an influence on the effect judgment of the study drug during the study period. (4)Sever liver/renal disease. (5)Woman who are pregnant or breast feeding, and woman of childbearing potential. (6)Patient who was considered ineligible by the investigators.

Design outcomes

Primary

Measure	Time frame
The symptom of a nose and eyes. Patient questionnaire.	—

Secondary

Measure	Time frame
Quality Of Life. Pollinosis diary. Side effect.	—

Countries

Japan

Contacts

Public ContactHideaki Shiga

Kanazawa Medical University Hospital Department of Otorhinolaryngology-Head and Neck Surgery

shigah@kanazawa-med.ac.jp076-286-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026